BMS-986337 / BMS - LARVOL DELTA

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986337 When Taken by Mouth by Healthy Participants (clinicaltrials.gov) - P1 | N=26 | Completed | Sponsor: Bristol-Myers Squibb | Not yet recruiting ➔ Completed | N=102 ➔ 26 | Trial completion date: Jul 2021 ➔ Mar 2021 | Trial primary completion date: Jul 2021 ➔ Mar 2021

Enrollment change • Trial completion • Trial completion date • Trial primary completion date